https://clinicaltrials.gov/ct2/show/NCT03845517?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F05%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus
Interventions : Drug: Placebo; Drug: PF-06700841 15 mg; Drug: PF-06700841 30 mg; Drug: PF-06700841 45 mg
Sponsor : Pfizer
Not yet recruiting
A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
NCT03845517
Tue, 19 Feb 2019 12:00:00 EST
